Skip to main content
. 2020 Feb 5;12(3):2246–2260. doi: 10.18632/aging.102743

Figure 3.

Figure 3

Genistein suppresses the degeneration of NPCs in vitro. (A) mRNA expression of COL2A in NPCs treated with IL-1β and Genistein or SB203580. *p>0.05 (B) mRNA expression of aggrecan in NPCs treated with IL-1β and Genistein or SB203580. *p>0.05 (C) mRNA expression of collagen X in NPCs treated with IL-1β and Genistein or SB203580. *p>0.05 (D) Toluidine blue staining and cell immuohistochemmistry stainingof NPCs treated with IL-1β and Genistein. Red scale bar represents 25 μm (E) mRNA expression of TNF-α in NPCs treated with IL-1β and Genistein or SB203580. *p<0.05 (F) mRNA expression of IL-1β in NPCs treated with IL-1β and Genistein or SB203580. *p<0.05.